BPC 157

Follow a proper titration schedule when adjusting your dosage. These ranges reflect common practitioner-guided protocols and do not reflect medical advice.

BPC 157 is a synthetic peptide composed of 15 amino acids derived from a partial sequence of a protein found in human gastric juice called body protection compound (BPC). It was developed to replicate the naturally occurring compound’s role in maintaining and repairing tissues in the digestive tract and other organs.

Studies in animals and limited human trials suggest that BPC 157 promotes healing of muscles, tendons, ligaments, and nerves. It has been shown to accelerate wound repair, improve angiogenesis, and enhance gastrointestinal protection and recovery after injury ^{1, 2}.

BPC‑157 has shown benefits primarily in animal studies for healing and regeneration of tissues. In rodent models of tendon injury, it accelerated tendon outgrowth, increased cell migration and survival under stress, and improved biomechanical strength of repaired tissue ³. Additionally, in models of spinal cord injury it improved motor function, preserved axons and reduced neuronal damage, suggesting benefits in nerve and tissue repair ⁴.

The peptide also appears to enhance angiogenesis and up-regulate growth factor receptors, which supports its healing benefits. For instance, it increased expression of growth hormone receptor in tendon fibroblasts, thereby potentially potentiating growth-hormone-mediated regeneration ⁵. A systematic review of musculoskeletal outcomes noted improvements in structure and function of muscle, tendon, ligament and bone injuries across pre-clinical studies ⁶. Overall, BPC-157 appears to promote healing, tissue regeneration, and protection across multiple organ systems, although its effects are primarily supported by preclinical animal research rather than confirmed human trials.

Currently, there is very limited evidence on the negative side-effects of BPC 157 in humans. A pilot study with two healthy adults found no measurable adverse effects when infused intravenously at up to 20 mg ⁷. Many preclinical toxicity studies in animals reported that the peptide was well tolerated, with no serious toxicity observed in mice, rats, rabbits or dogs ⁸.

Despite the favorable short-term data, some theoretical and anecdotal concerns exist. One concern is that BPC 157 may promote angiogenesis (the growth of new blood vessels), which in certain contexts could potentially support tumor growth. Because controlled human trials are absent, any side-effect profile remains largely unknown ⁹.